Roche and Molecular Partners have entered into a research and licensing alliance to discover, develop and commercialize new cancer treatments. The agreement will incorporate Molecular Partners ...
Roche seems determined to develop a commanding position in the emerging molecular glue category, signing up to a $2 billion partnership with Monte Rosa Therapeutics that includes a $50 million ...
Hosted on MSN1mon
Roche’s STI assay panels gain FDA 510(k) clearance and CLIA waiverRoche Diagnostics CEO Matt Sause said: “Rapid molecular point-of-care testing can revolutionise the clinical management of STIs in decentralised and community-based healthcare settings ...
Roche, together with other industry partners, recently took part in an EMA-led ‘Workshop on the role of registries in the monitoring of cancer therapies based on genetic and molecular features’.
“Rapid molecular point-of-care testing can revolutionise ... said Matt Sause, CEO Roche Diagnostics. More than 1 million people worldwide acquire an STI every day. Common STIs often present ...
Roche, via their African Genomics Program ... Gordon Awandare, Professor of Biochemistry, Cell and Molecular Biology and Pro-Vice Chancellor of the University of Ghana. “Through partnerships like TACA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback